BackIdeaya Biosciences Overview
Ideaya Biosciences Inc

Ideaya Biosciences Target Price

Analysts' 12-month price predictions for IDYA.

Get informed when a big investor buys or sells

+ Follow

Share Price

$28.4

Average Target Price

$57.00100.7% upside

4 analysts in the last 4 months

High: $65 | Low: $52

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-04-14Wedbush$58104.2% upsideOpen
2026-04-14RBC Capital$5386.6% upsideOpen
2026-04-13Truist Financial$65128.9% upsideOpen
2026-02-18Wedbush$5283.1% upsideOpen
2026-01-21RBC Capital$4558.5% upsideOpen
2026-01-06Truist FinancialGregory Renza$60111.3% upsideOpen
2025-11-24Truist Financial$59107.7% upsideOpen
2025-10-21New Street$305.6% upsideOpen
2025-10-21RBC Capital$4144.4% upsideOpen
2025-09-17Guggenheim$5076.1% upsideOpen
2025-09-09RBC CapitalGregory Renza$3833.8% upsideOpen
2025-09-08OppenheimerMatthew Biegler$3626.8% upsideOpen
2025-09-04JMP Securitieslvan Tuerkcan$4144.4% upsideOpen
2025-09-04Barclays$4040.8% upsideOpen
2024-11-05Leerink PartnersAndrew Berens$274.9% downsideOpen
2024-10-24UBSDavid Dai$5076.1% upsideOpen
2024-09-25Mizuho SecuritiesGraig Suvannavejh$5593.7% upsideOpen
2024-09-23Goldman SachsCorinne Jenkins$4869% upsideOpen
2024-09-23Stifel NicolausBen Burnett$66132.4% upsideOpen
2024-09-23BTIGJustin Zelin$62118.3% upsideOpen
2024-09-10Stifel NicolausBen Burnett$68139.4% upsideOpen
2024-08-27CitigroupYigal Nochomovitz$58104.2% upsideOpen
2024-08-07OppenheimerMatthew Biegler$5386.6% upsideOpen
2024-07-10RBC CapitalGregory Renza$61114.8% upsideOpen
2024-07-08Mizuho SecuritiesGraig Suvannavejh$5076.1% upsideOpen
2024-06-03Stifel NicolausBen Burnett$63121.8% upsideOpen
2022-12-28Capital One Financial$292.1% upsideOpen
2022-09-13Guggenheim$3212.7% upsideOpen
2022-08-18Oppenheimer$2029.6% downsideOpen
2022-08-16Robert W. Baird$1836.6% downsideOpen